Trial intelligence / Profile preview

Traumeel vs dexamethasone injection for rotator cuff syndrome and bursitis

2012-003393-12Phase 3Completed

Sponsor
Heel
Start
Oct 2012
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of Traumeel S in Rotator cuff deficiency (RCD) and shoulder bursitis (2 arms), sponsored by Heel. Primary endpoint: Patient evaluation of shoulder pain. Started Oct 2012; status: completed.

02

Drugs

Traumeel S
03

Conditions

Rotator cuff deficiency (RCD)shoulder bursitis

Beyond the preview

Go deeper on 2012-003393-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003393-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call